Steven Waggoner

Also affiliated with Case Western Reserve University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women”.

The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women

Gynecologic Oncology(2021)10.1016/j.ygyno.2020.12.040

N/A

0.941DataRank · unranked

26 citations

Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille C. Gunderson, Casey Cosgrove +15 more

Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group

Journal of Clinical Oncology(2009)10.1200/jco.2008.19.2963

N/A

0.747DataRank · unranked

144 citations

John A. Blessing, Carolyn N. Krasner, Robert S. Mannel, Parviz Hanjani, Michael L. Pearl +5 more

A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6003

N/A

0.606DataRank · unranked

56 citations

Mark F. Brady, Ursula A. Matulonis, Austin Miller, Elise C. Kohn, Elizabeth M. Swisher +15 more

Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.08.005

N/A

0.360DataRank · unranked

10 citations

Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille Gunderson Jackson, Casey Cosgrove +14 more

Small molecule mediated stabilization of PP2A modulates the Homologous Recombination pathway and potentiates DNA damage-induced cell death

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.10.495657

N/A

0.104DataRank · unranked

1 citations

Amy J. Armstrong, Gracie Carvette, Noah Puleo, Riya Gupta, Jose A. Colina +17 more

Patient-reported outcomes during pelvic radiation therapy: A secondary analysis on sexual function from NRG-RTOG 1203.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5533

N/A

0DataRank · unranked

1 citations

Rebecca Paulus, Ann H. Klopp, Lari Wenzel, Anamaria R. Yeung, J. S. Thompson +15 more

Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.03.027

N/A

0DataRank · unranked

20 citations

Danielle Enserro, Matthew S. Block, Steven Waggoner, Linda Duska, Andrea E. Wahner-Hendrickson +11 more

Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for newly diagnosed primary CNS lymphoma (PCNSL).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2501

N/A

0DataRank · unranked

59 citations

Lisa M. DeAngelis, Theodore Karrison, Joe A Bovi, Marc K. Rosenblum, Benjamin W. Corn +16 more

A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.003

N/A

0DataRank · unranked

9 citations

Michael W. Sill, Paola A. Gehrig, Jason D. Merker, David L. Corcoran, Adam D. Pfefferle +15 more

Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol

UNC Libraries(2020)10.17615/5jcw-ca69

N/A

0DataRank · unranked

0 citations

David S. Miller, Steven Waggoner, Robert P. Edwards, Saketh R. Guntupalli, Matthew A. Powell +13 more

Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.06.017

N/A

0DataRank · unranked

62 citations

Anna Beavis, Christopher Purdy, Anne F. Rositch, Akila N. Viswanathan, Aaron H. Wolfson +16 more